Shawn Hodges, PharmD, CEO of Revelation Pharma discusses how compounding pharmacies may help solve the ongoing issue with #drugshortages 💬🗨️
Pharmaceutical Executive’s Post
More Relevant Posts
-
BioPharma & HealthTech Competitive Strategy & Insights | Digital & AI Solutions | Gene & Cell Therapy | Vaccines
Thoughts on this? >> Available for Preorder: The 2024 Economic Report on U.S. Pharmacies and Pharmacy Benefit Managers >> Comment below! >>> lqventures.com #strategy #competitiveintelligence #marketing #biotech #pharmaceutical #healthcare #productmarketing #pharma
Available for Preorder: The 2024 Economic Report on U.S. Pharmacies and Pharmacy Benefit Managers
drugchannels.net
To view or add a comment, sign in
-
Thoughts on this? >> Available for Preorder: The 2024 Economic Report on U.S. Pharmacies and Pharmacy Benefit Managers >> Comment below! >>> lqventures.com #strategy #competitiveintelligence #marketing #pharmaceutical #productmarketing #biotech #healthcare #pharma
Available for Preorder: The 2024 Economic Report on U.S. Pharmacies and Pharmacy Benefit Managers
drugchannels.net
To view or add a comment, sign in
-
This is an insightful article on compounding pharmacies' challenges in providing diabetes and weight loss treatments. Highlights include misconceptions surrounding compounded products, legal disputes from major pharmaceutical companies, and the Alliance for Pharmacy Compounding's efforts to address these issues. Despite concerns, success stories from clinicians underscore the value of compounded medications for patients. #Healthcare #CompoundingPharmacies
Compounders: Don't Listen to Bad Press on GLP-1s
medscape.com
To view or add a comment, sign in
-
The Big Three PBMs’ 2024 Formulary Exclusions: Biosimilar Humira Battles, CVS Health’s Weird Strategy, and the Insulin Shakeup >>> lqventures.com #strategy #competitiveintelligence #marketing #productmarketing #pharma #pharmaceutical #healthcare #biotech
The Big Three PBMs’ 2024 Formulary Exclusions: Biosimilar Humira Battles, CVS Health’s Weird Strategy, and the Insulin Shakeup
drugchannels.net
To view or add a comment, sign in
-
Drug Channels News Roundup, February 2024: Pharmacy Shakeout Update, High Drug Prices, 340B Realities, MDs vs. Pharmacists, and Foo Fighters >>> lqventures.com #strategy #competitiveintelligence #marketing #biotech #productmarketing #healthcare #pharmaceutical #pharma
Drug Channels News Roundup, February 2024: Pharmacy Shakeout Update, High Drug Prices, 340B Realities, MDs vs. Pharmacists, and Foo Fighters
drugchannels.net
To view or add a comment, sign in
-
Thoughts on this? >> The Top 15 U.S. Pharmacies of 2023: Market Shares and Revenues at the Biggest Chains and PBMs >> Comment below! >>> lqventures.com #strategy #competitiveintelligence #marketing #pharma #pharmaceutical #productmarketing #healthcare #biotech
The Top 15 U.S. Pharmacies of 2023: Market Shares and Revenues at the Biggest Chains and PBMs
drugchannels.net
To view or add a comment, sign in
-
Pfizer and Eli Lilly within the last year have both announced "direct to consumer" models of delivering GLP-1 agents (and perhaps select other drugs) from manufacturer to patient--bypassing the complexities of the pharmaceutical supply chain, including it would seem traditional pharmacies. This follows in the success of Hims, a San Francisco based tech/healthcare startup which has reached a market cap of $3.12 billion and continues to expand. Pharmacy friends, what does this mean for the future of our profession? Is DTC here to stay? Does this model allow pharmaceutical manufacturers to perhaps exert even more power and influence over our healthcare system with putting prescribers even more directly on their payroll? Or will DTC help to increase transparency in the overall system, and expand healthcare access to patients, particularly those in rural areas? Is the net effect good, bad or indifferent? #healthcare #healthcareaccess #pharma #pharmacy
Pfizer joins direct-to-consumer drug sales
axios.com
To view or add a comment, sign in
-
BioPharma & HealthTech Competitive Strategy & Insights | Digital & AI Solutions | Gene & Cell Therapy | Vaccines
Drug Channels News Roundup, February 2024: Pharmacy Shakeout Update, High Drug Prices, 340B Realities, MDs vs. Pharmacists, and Foo Fighters >>> lqventures.com #strategy #competitiveintelligence #marketing #biotech #pharma #productmarketing #healthcare #pharmaceutical
Drug Channels News Roundup, February 2024: Pharmacy Shakeout Update, High Drug Prices, 340B Realities, MDs vs. Pharmacists, and Foo Fighters
drugchannels.net
To view or add a comment, sign in
-
BioPharma & HealthTech Competitive Strategy & Insights | Digital & AI Solutions | Gene & Cell Therapy | Vaccines
Thoughts on this? >> The Top 15 U.S. Pharmacies of 2023: Market Shares and Revenues at the Biggest Chains and PBMs >> Comment below! >>> lqventures.com #strategy #competitiveintelligence #marketing #biotech #pharma #productmarketing #pharmaceutical #healthcare
The Top 15 U.S. Pharmacies of 2023: Market Shares and Revenues at the Biggest Chains and PBMs
drugchannels.net
To view or add a comment, sign in
-
Thoughts on this? >> Hospitals Are Relying More on PBMs to Manage Manufacturers' 340B Contract Pharmacy Restrictions: DCI's 2024 Market Analysis >> Comment below! >>> lqventures.com #strategy #competitiveintelligence #marketing #pharma #productmarketing #healthcare #biotech #pharmaceutical
Hospitals Are Relying More on PBMs to Manage Manufacturers' 340B Contract Pharmacy Restrictions: DCI's 2024 Market Analysis
drugchannels.net
To view or add a comment, sign in
25,751 followers